Complex Regional Pain Syndrome (CRPS) of the Foot: Diagnosis and Multidisciplinary Treatment

What Is Complex Regional Pain Syndrome?

Complex regional pain syndrome (CRPS) — formerly called reflex sympathetic dystrophy (RSD) or causalgia — is a chronic, debilitating pain condition characterized by pain that is disproportionate in intensity and duration to any inciting injury, accompanied by sensory, motor, and autonomic disturbances. CRPS is classified into two types: Type I (formerly RSD), occurring without a defined nerve injury, and Type II (formerly causalgia), occurring in the distribution of a damaged peripheral nerve. The foot and ankle is one of the most common locations for CRPS Type I development, frequently precipitated by ankle fractures, ankle surgery, ankle sprain, or even seemingly minor foot trauma.

CRPS is not a diagnosis of exclusion — it is a recognized clinical syndrome with defined diagnostic criteria (the Budapest Criteria). However, it remains underdiagnosed and undertreated due to its complex, multisystem presentation that does not conform to the expected injury-recovery trajectory. Recognition and early treatment within the first 3–6 months of symptom onset dramatically improves outcomes compared to delayed diagnosis.

Budapest Diagnostic Criteria

To meet Budapest Criteria for CRPS diagnosis, a patient must demonstrate:

Continuing pain disproportionate to the inciting event — the pain exceeds what is expected from the original injury in both intensity and duration.

At least one symptom in 3 of 4 categories:

• Sensory: hyperesthesia (increased sensitivity to normal stimuli) or allodynia (pain from normally non-painful stimuli like light touch or clothing contact)
• Vasomotor: temperature asymmetry between affected and unaffected limb; skin color changes (red, blue, mottled, pale)
• Sudomotor/edema: sweating changes; asymmetric edema
• Motor/trophic: decreased range of motion; motor dysfunction (weakness, tremor, dystonia); trophic changes (nail, skin, or hair abnormalities)

At least one sign in 2 of 4 categories confirmed on examination.

No other diagnosis that would better explain the symptoms.

Pathophysiology: Why CRPS Develops

The underlying mechanism of CRPS remains incompletely understood, but current evidence supports a model involving three interacting systems: central sensitization of pain processing in the spinal cord and brain (neuroplastic changes that amplify pain signaling); sympathetic nervous system dysregulation (producing the vasomotor, sudomotor, and trophic changes); and neurogenic inflammation (neuropeptide release from peripheral sensory nerves perpetuating local inflammation beyond the original injury). The relative contribution of each mechanism varies between patients, explaining the heterogeneous clinical presentations and variable response to different treatments.

Stages of CRPS

CRPS traditionally progresses through three stages, though this staging is not universal and may overlap:

Stage 1 (Acute, 0–3 months): Burning or throbbing pain; skin warm, red, dry; mild to moderate edema; pain worsens with movement or dependent position; X-rays may show patchy osteoporosis. This is the stage where intervention is most effective.

Stage 2 (Dystrophic, 3–9 months): Pain persists; skin becomes cool and cyanotic (blue-purple); edema becomes brawny (firm); hair and nail growth abnormalities; muscle weakness and range of motion loss; X-rays show progressive osteoporosis.

Stage 3 (Atrophic, beyond 9 months): Pain may partially diminish but disability progresses; skin is pale, cool, and atrophic; severe contractures; significant osteoporosis. Stage 3 is much less responsive to treatment than earlier stages.

Treatment: The Functional Restoration Approach

CRPS treatment is multidisciplinary, targeting pain reduction to enable functional restoration. The most effective treatment paradigm — consistent across international guidelines — places functional rehabilitation at the center, with pharmacological and interventional treatments as pain-reduction enablers that allow the patient to participate in rehabilitation rather than as primary cures.

Physical and Occupational Therapy

Graded motor imagery (GMI) — a sequence of limb laterality recognition, imagined movements, and mirror visual feedback — reduces central sensitization and cortical reorganization that perpetuates CRPS pain. Graded exposure therapy progressively reintroduces movement and weight-bearing to the affected foot, gradually reducing the allodynic response through desensitization. These therapies, delivered by therapists experienced with CRPS management, are the most robustly evidence-supported treatment modalities available.

Pharmacological Management

No pharmacological agent is specifically FDA-approved for CRPS; treatment is empirical and guided by symptom pattern. Neuropathic pain agents (gabapentin, pregabalin, duloxetine, low-dose tricyclic antidepressants) address central sensitization. Bisphosphonates (alendronate, pamidronate) have demonstrated efficacy in reducing CRPS pain and bone loss in controlled trials. Vitamin C supplementation (500–1000mg daily) has evidence for CRPS prevention after distal radius and ankle fractures. Short-course corticosteroids may reduce acute inflammation in early CRPS. Topical agents (compounded ketamine, lidocaine) provide localized analgesia with minimal systemic effect.

Interventional Procedures

Sympathetic nerve blocks — lumbar sympathetic blocks for lower extremity CRPS — disrupt sympathetically maintained pain and, if effective, provide a window of pain reduction during which intensive rehabilitation can proceed. Spinal cord stimulation — electrical stimulation of the dorsal columns of the spinal cord through implanted leads — is the most evidence-supported interventional treatment for refractory CRPS, demonstrating superior long-term outcomes to conventional medical management in randomized trials. Ketamine infusion therapy and low-dose naltrexone are emerging treatments with promising early evidence for refractory CRPS.

The Critical Importance of Early Diagnosis

Any patient with disproportionate or prolonged pain, skin color or temperature changes, sweating abnormalities, or significant swelling and range-of-motion loss following foot or ankle injury or surgery should be evaluated promptly for CRPS. Early diagnosis — within the first 3 months — is associated with significantly better outcomes than diagnosis after stage progression. If you have a patient or family member with unexplained, severe post-injury foot pain that is not responding to standard treatment, prompt evaluation by a podiatrist or pain specialist with CRPS experience is warranted.

When Shoes Aren’t Enough — Dr. Tom’s Top 9 Orthotics

About 30% of patients I see for foot pain need MORE than a great shoe — they need a structured insole. Below: my complete 2026 orthotic ranking with pros, cons, and the specific patient I’d give each one to.

No products found.